Table 2.
Difference of variables between patients who died within one year and patients who lived longer.
| Factor | Death within 1 Year | 1 Year Survival | p Value |
|---|---|---|---|
| Number | 15 | 88 | |
| Proportion of female | 40.0% (6/15) | 50.0% (44/88) | 0.581 |
| Diagnosis age | 72 (64.5–81.5) | 64 (51.0–70.5) | 0.009 ** |
| WBC (/µL) | 6220 (5570–9005) | 5950 (4783–7393) | 0.217 |
| Plate (×104/µL) | 26.3 (21.9–30.9) | 24.2 (19.8–28.6) | 0.231 |
| T- cholesterol (mg/dl) | 204.1 ± 35.7 | 189.3 ± 39.4 | 0.178 |
| GPS | 1.0 (1.0–2.0) | 0.0 (0.0–0.0) | <0.001 ** |
| GNRI | 89.3 (86.0–95.3) | 104.2 (98.2–108.7) | <0.001 ** |
| NLR | 4.0 (2.6–5.8) | 2.2 (1.6–3.0) | 0.003 ** |
| PLR | 19.6 (15.5–26.7) | 14.6 (11.7–17.7) | 0.003 ** |
| CONUT score | 3.0 (2.0–4.5) | 1.0 (0.0–2.0) | <0.001 ** |
| Maximum diameter of tumor | 112.0 (94.0–150.0) | 65.5 (40.8–94.3) | <0.001 ** |
| Proportion of trunk onset | 26.7% (4/15) | 19.3% (17/88) | 0.50 |
| Stage (cases) | 1(0)/2(1)/3(9)/4(5) | 1(0)/2(31)/3(51)/4(6) | 0.002 ** |
| Proportion of resectable STS | 53.3% (8/15) | 96.6% (85/88) | <0.001 ** |
Abbreviations: WBC: white blood cell; GNRI: geriatric nutritional risk index; GPS: Glasgow prognostic score; NLR: neutrophil–lymphocyte ratio; PLR: platelet–lymphocyte ratio; CONUT score: controlling nutritional status score; STS: soft tissue sarcoma; ** p < 0.01